Trial Profile
Management of Hyperglycemia in the Emergency Room: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2022
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin detemir
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms NOVO-ER
- 03 Feb 2010 Status changed from discontinued to completed as reported by ClinicalTrials.gov (NCT00591227).
- 03 Feb 2010 Status changed from discontinued to completed as reported by ClinicalTrials.gov (NCT00591227).
- 03 Feb 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.